Application of recombinant protein technologies in the development of innovative medical devices for BV treatment (Q3798321): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in es: Adding Spanish translations) |
(Removed claims) |
||||||
| Property / instance of | |||||||
| Property / instance of: Kohesio project / rank | |||||||
| Property / financed by | |||||||
| Property / financed by: European Union / rank | |||||||
| Property / country | |||||||
| Property / country: Lithuania / rank | |||||||
| Property / budget | |||||||
| |||||||
| Property / budget: 1,110,770.11 Euro / rank | |||||||
| Property / beneficiary name (string) | |||||||
| Property / beneficiary name (string): Uždaroji akcinė bendrovė "Profarma" / rank | |||||||
| Property / beneficiary | |||||||
| Property / beneficiary: Q3815949 / rank | |||||||
Revision as of 05:37, 1 February 2022
Project Q3798321 in Lithuania
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Application of recombinant protein technologies in the development of innovative medical devices for BV treatment |
Project Q3798321 in Lithuania |
Statements
Identifiers
J05-LVPA-K-04-0085
0 references